25 XP   0   0   10

LifeMD Inc
Buy, Hold or Sell?

Let's analyse Lifemd together

PenkeI guess you are interested in LifeMD Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of LifeMD Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about LifeMD Inc

I send you an email if I find something interesting about LifeMD Inc.

Quick analysis of Lifemd (30 sec.)










What can you expect buying and holding a share of Lifemd? (30 sec.)

How much money do you get?

How much money do you get?
$0.08
When do you have the money?
1 year
How often do you get paid?
42.5%

What is your share worth?

Current worth
$0.14
Expected worth in 1 year
$0.47
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
$0.41
Return On Investment
4.2%

For what price can you sell your share?

Current Price per Share
$9.70
Expected price per share
$8.93 - $12.01
How sure are you?
50%

1. Valuation of Lifemd (5 min.)




Live pricePrice per Share (EOD)

$9.70

Intrinsic Value Per Share

$-3.33 - $12.55

Total Value Per Share

$-3.19 - $12.69

2. Growth of Lifemd (5 min.)




Is Lifemd growing?

Current yearPrevious yearGrowGrow %
How rich?$5.5m$4.7m-$10.5m-182.1%

How much money is Lifemd making?

Current yearPrevious yearGrowGrow %
Making money-$6.6m-$11.6m$4.9m74.6%
Net Profit Margin-18.3%-39.3%--

How much money comes from the company's main activities?

3. Financial Health of Lifemd (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

What can you expect buying and holding a share of Lifemd? (5 min.)

Welcome investor! Lifemd's management wants to use your money to grow the business. In return you get a share of Lifemd.

What can you expect buying and holding a share of Lifemd?

First you should know what it really means to hold a share of Lifemd. And how you can make/lose money.

Speculation

The Price per Share of Lifemd is $9.7. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lifemd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lifemd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.14. Based on the TTM, the Book Value Change Per Share is $0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lifemd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-1.0%-0.14-1.5%-0.31-3.2%-0.25-2.6%-0.13-1.4%
Usd Book Value Change Per Share0.434.4%0.080.8%-0.21-2.2%0.010.1%0.000.0%
Usd Dividend Per Share0.020.2%0.020.2%0.020.2%0.010.1%0.010.1%
Usd Total Gains Per Share0.454.6%0.101.1%-0.19-2.0%0.020.2%0.010.1%
Usd Price Per Share8.29-5.15-2.37-3.85-2.04-
Price to Earnings Ratio-21.71--10.20--1.94--4.30-19.52-
Price-to-Total Gains Ratio18.59--587.66--14.73--125.16-3.42-
Price to Book Ratio58.22-2.62-8.68--10.04-3.59-
Price-to-Total Gains Ratio18.59--587.66--14.73--125.16-3.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.7
Number of shares103
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.080.01
Usd Total Gains Per Share0.100.02
Gains per Quarter (103 shares)10.532.07
Gains per Year (103 shares)42.108.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18343263-2
21668741256
32510211617814
433136158231022
541170200291330
649204242351538
757237284411846
865271326462054
974305368522362
1082339410582570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%2.046.00.04.2%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.014.01.025.0%14.023.03.035.0%17.025.06.035.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%13.00.07.065.0%17.00.023.042.5%17.00.031.035.4%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%6.013.01.030.0%17.022.01.042.5%20.024.04.041.7%

Fundamentals of Lifemd

About LifeMD Inc

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-04-11 13:15:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of LifeMD Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lifemd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • A Net Profit Margin of -8.3% means that $-0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of LifeMD Inc:

  • The MRQ is -8.3%. The company is making a loss. -1
  • The TTM is -18.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-8.3%TTM-18.3%+10.0%
TTM-18.3%YOY-39.3%+21.0%
TTM-18.3%5Y-56.7%+38.4%
5Y-56.7%10Y-49.3%-7.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.3%-20.7%+12.4%
TTM-18.3%-20.0%+1.7%
YOY-39.3%-30.6%-8.7%
5Y-56.7%-35.6%-21.1%
10Y-49.3%-43.2%-6.1%
1.1.2. Return on Assets

Shows how efficient Lifemd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • -6.4% Return on Assets means that Lifemd generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of LifeMD Inc:

  • The MRQ is -6.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.4%TTM-17.5%+11.2%
TTM-17.5%YOY-32.9%+15.4%
TTM-17.5%5Y-71.2%+53.6%
5Y-71.2%10Y-52.6%-18.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.4%-6.7%+0.3%
TTM-17.5%-6.5%-11.0%
YOY-32.9%-5.9%-27.0%
5Y-71.2%-6.2%-65.0%
10Y-52.6%-8.4%-44.2%
1.1.3. Return on Equity

Shows how efficient Lifemd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • -106.5% Return on Equity means Lifemd generated $-1.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of LifeMD Inc:

  • The MRQ is -106.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-106.5%TTM-26.6%-79.9%
TTM-26.6%YOY-115.4%+88.8%
TTM-26.6%5Y-170.5%+143.9%
5Y-170.5%10Y-121.0%-49.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-106.5%-6.6%-99.9%
TTM-26.6%-7.2%-19.4%
YOY-115.4%-7.7%-107.7%
5Y-170.5%-9.6%-160.9%
10Y-121.0%-9.6%-111.4%

1.2. Operating Efficiency of LifeMD Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lifemd is operating .

  • Measures how much profit Lifemd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • An Operating Margin of -4.8% means the company generated $-0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of LifeMD Inc:

  • The MRQ is -4.8%. The company is operating very inefficient. -2
  • The TTM is -9.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4.8%TTM-9.7%+4.9%
TTM-9.7%YOY-33.4%+23.7%
TTM-9.7%5Y-48.9%+39.2%
5Y-48.9%10Y-38.0%-10.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.8%-20.9%+16.1%
TTM-9.7%-18.5%+8.8%
YOY-33.4%-22.8%-10.6%
5Y-48.9%-19.6%-29.3%
10Y-38.0%-31.6%-6.4%
1.2.2. Operating Ratio

Measures how efficient Lifemd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are $1.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of LifeMD Inc:

  • The MRQ is 1.048. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.097. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.048TTM1.097-0.049
TTM1.097YOY1.334-0.237
TTM1.0975Y1.516-0.419
5Y1.51610Y1.496+0.020
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0481.343-0.295
TTM1.0971.383-0.286
YOY1.3341.383-0.049
5Y1.5161.394+0.122
10Y1.4961.324+0.172

1.3. Liquidity of LifeMD Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lifemd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.22 means the company has $1.22 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of LifeMD Inc:

  • The MRQ is 1.225. The company is just able to pay all its short-term debts.
  • The TTM is 0.835. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.225TTM0.835+0.390
TTM0.835YOY0.688+0.147
TTM0.8355Y0.818+0.017
5Y0.81810Y1.045-0.227
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2251.770-0.545
TTM0.8351.811-0.976
YOY0.6882.055-1.367
5Y0.8182.582-1.764
10Y1.0452.668-1.623
1.3.2. Quick Ratio

Measures if Lifemd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • A Quick Ratio of 1.10 means the company can pay off $1.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of LifeMD Inc:

  • The MRQ is 1.105. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.685. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.105TTM0.685+0.420
TTM0.685YOY0.538+0.147
TTM0.6855Y0.569+0.116
5Y0.56910Y0.668-0.099
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1051.059+0.046
TTM0.6851.185-0.500
YOY0.5381.813-1.275
5Y0.5691.992-1.423
10Y0.6682.044-1.376

1.4. Solvency of LifeMD Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lifemd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lifemd to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.90 means that Lifemd assets are financed with 90.5% credit (debt) and the remaining percentage (100% - 90.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of LifeMD Inc:

  • The MRQ is 0.905. The company is just able to pay all its debts by selling its assets.
  • The TTM is 1.171. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ0.905TTM1.171-0.266
TTM1.171YOY0.922+0.249
TTM1.1715Y1.321-0.150
5Y1.32110Y1.160+0.161
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9050.381+0.524
TTM1.1710.385+0.786
YOY0.9220.407+0.515
5Y1.3210.411+0.910
10Y1.1600.448+0.712
1.4.2. Debt to Equity Ratio

Measures if Lifemd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lifemd to the Health Information Services industry mean.
  • A Debt to Equity ratio of 1,509.5% means that company has $15.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of LifeMD Inc:

  • The MRQ is 15.095. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.774. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ15.095TTM3.774+11.321
TTM3.774YOY3.430+0.344
TTM3.7745Y2.311+1.462
5Y2.31110Y2.249+0.062
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ15.0950.600+14.495
TTM3.7740.578+3.196
YOY3.4300.608+2.822
5Y2.3110.718+1.593
10Y2.2490.610+1.639

2. Market Valuation of LifeMD Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lifemd generates.

  • Above 15 is considered overpriced but always compare Lifemd to the Health Information Services industry mean.
  • A PE ratio of -21.71 means the investor is paying $-21.71 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of LifeMD Inc:

  • The EOD is -25.398. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.707. Based on the earnings, the company is expensive. -2
  • The TTM is -10.204. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-25.398MRQ-21.707-3.692
MRQ-21.707TTM-10.204-11.503
TTM-10.204YOY-1.944-8.260
TTM-10.2045Y-4.295-5.908
5Y-4.29510Y19.523-23.818
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-25.398-1.464-23.934
MRQ-21.707-2.160-19.547
TTM-10.204-1.939-8.265
YOY-1.944-3.761+1.817
5Y-4.295-4.657+0.362
10Y19.523-5.128+24.651
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of LifeMD Inc:

  • The EOD is 27.106. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 23.166. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -2.113. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD27.106MRQ23.166+3.940
MRQ23.166TTM-2.113+25.279
TTM-2.113YOY-3.218+1.105
TTM-2.1135Y-2.984+0.871
5Y-2.98410Y-12.348+9.364
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD27.106-1.643+28.749
MRQ23.166-2.152+25.318
TTM-2.113-3.287+1.174
YOY-3.218-5.550+2.332
5Y-2.984-3.884+0.900
10Y-12.348-3.140-9.208
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lifemd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 58.22 means the investor is paying $58.22 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of LifeMD Inc:

  • The EOD is 68.119. Based on the equity, the company is expensive. -2
  • The MRQ is 58.217. Based on the equity, the company is expensive. -2
  • The TTM is 2.622. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD68.119MRQ58.217+9.902
MRQ58.217TTM2.622+55.595
TTM2.622YOY8.684-6.062
TTM2.6225Y-10.042+12.663
5Y-10.04210Y3.594-13.635
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD68.1191.577+66.542
MRQ58.2171.856+56.361
TTM2.6221.880+0.742
YOY8.6843.040+5.644
5Y-10.0423.953-13.995
10Y3.5944.099-0.505
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of LifeMD Inc.

3.1. Institutions holding LifeMD Inc

Institutions are holding 31.086% of the shares of LifeMD Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Divisadero Street Capital Management, LP4.72423.459184662364331653.4623
2023-12-31Vanguard Group Inc2.62610.00021026492760287.999
2023-12-31Amvescap Plc.2.17790.00178512918512910
2023-12-31Royce & Associates, LP2.13010.0638832626-263882-24.0657
2023-12-31G2 Investment Partners Management LLC1.76021.672468805013285023.9283
2023-12-31EAM Investors, LLC1.36410.78415332125668411.8952
2023-12-31BlackRock Inc1.30450.000150990312744233.3216
2023-12-31Next Century Growth Investors LLC1.04580.329640878119500.4793
2023-12-31Susquehanna International Group, LLP0.95730.0006374205224349149.7097
2023-12-31Morgan Stanley - Brokerage Accounts0.8840.0003345559197785133.8429
2023-12-31American Financial Group Inc0.86981.036834000000
2023-12-31Qube Research & Technologies0.86370.00553375923306964795.4756
2023-12-31Marshall Wace Asset Management Ltd0.82350.0045321891-106695-24.8947
2023-12-31Geode Capital Management, LLC0.74720.00032920792935111.1716
2023-12-31JANE STREET GROUP, LLC0.57390.0005224324200607845.8363
2023-12-31Renaissance Technologies Corp0.49480.00251934008960086.3198
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC0.47630.03941861787286964.31
2023-12-31Barry Investment Advisors, LLC0.45630.500217836900
2023-09-30Point72 Asset Management, L.P.0.44050.00311722031722030
2023-12-31Bank of New York Mellon Corp0.41820.0003163459131847417.079
Total 25.13847.90499826237+2968291+30.2%

3.2. Funds holding LifeMD Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28Invesco Dorsey Wright SmallCap Momt ETF3.11471.0817121747900
2024-02-29Vanguard Total Stock Mkt Idx Inv1.76920.000469156900
2023-12-31Royce Small-Cap Opportunity Invmt1.34660.3391526366-183839-25.8853
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.04090.003240686053001.3199
2023-12-31FTGF RY US SmCp Opp A USD Dis(A)0.73370.3307286794-74554-20.6322
2024-02-29Fidelity Extended Market Index0.3990.0032155961-756-0.4824
2023-12-31Next Century Growth Micro Cap Growth0.28290.813611056600
2023-12-31Pleiades Small Cap Equity A0.22190.079986723-34173-28.2664
2023-12-31Acuitas US Microcap Strategy0.18780.16273400734000
2024-03-28iShares Micro-Cap ETF0.16630.0727649908041.2526
2024-03-31BlackRock Extended Equity Market K0.15820.004461857220.0356
2023-12-31Bridgeway Ultra-Small Company Market0.1420.247655500-52800-48.7535
2024-02-29Fidelity Total Market Index0.1190.00044651200
2023-09-30BlackRock Extended Mkt Composite0.11390.0024450900
2023-12-31Ancora/Thelen Small Cap Core0.11320.514644250442500
2024-02-29Fidelity Series Total Market Index0.0960.00043752500
2024-03-28iShares Core S&P Total US Stock Mkt ETF0.0860.000633622-28-0.0832
2024-02-29Russell Inv Small Cap Fund B0.08370.0533271800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07690.00430074762933.9898
2024-02-29Fidelity Nasdaq Composite Index0.06840.00142673400
Total 10.32033.71494034009-214745-5.3%

3.3. Insider Transactions

Insiders are holding 19.806% of the shares of LifeMD Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-31Bertrand VelgeBUY600003.93
2023-08-29Bertrand VelgeBUY320723.58
2023-06-14Nicholas P AlvarezBUY107122.92
2023-06-13Bertrand VelgeBUY443652.64
2023-06-13Eric Harold YeciesBUY115002.6
2023-06-07Bertrand VelgeBUY245002.19
2023-06-05Bertrand VelgeBUY103832.17
2023-05-23Stefan GalluppiBUY100002.17
2023-05-22Justin SchreiberBUY176642.15

4. Summary

4.1. Key Performance Indicators

The key performance indicators of LifeMD Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4260.082+417%-0.212+150%0.006+6916%0.003+12301%
Book Value Per Share--0.142-0.148+204%0.121+18%-0.018+112%-0.006+105%
Current Ratio--1.2250.835+47%0.688+78%0.818+50%1.045+17%
Debt To Asset Ratio--0.9051.171-23%0.922-2%1.321-31%1.160-22%
Debt To Equity Ratio--15.0953.774+300%3.430+340%2.311+553%2.249+571%
Dividend Per Share--0.0200.0200%0.0200%0.014+41%0.007+166%
Eps---0.095-0.142+48%-0.311+226%-0.255+167%-0.131+38%
Free Cash Flow Per Share--0.0890.001+15988%-0.229+356%-0.109+222%-0.057+163%
Free Cash Flow To Equity Per Share--0.4570.187+145%-0.233+151%0.044+949%0.021+2062%
Gross Profit Margin--6.4634.314+50%2.710+139%3.025+114%2.566+152%
Intrinsic Value_10Y_max--12.547--------
Intrinsic Value_10Y_min---3.332--------
Intrinsic Value_1Y_max---0.012--------
Intrinsic Value_1Y_min---0.572--------
Intrinsic Value_3Y_max--0.932--------
Intrinsic Value_3Y_min---1.522--------
Intrinsic Value_5Y_max--3.042--------
Intrinsic Value_5Y_min---2.250--------
Market Cap379158450.000+15%324043665.000201208053.750+61%92639745.000+250%150471180.750+115%79681907.250+307%
Net Profit Margin---0.083-0.183+120%-0.393+373%-0.567+582%-0.493+492%
Operating Margin---0.048-0.097+101%-0.334+590%-0.489+910%-0.380+684%
Operating Ratio--1.0481.097-4%1.334-21%1.516-31%1.496-30%
Pb Ratio68.119+15%58.2172.622+2121%8.684+570%-10.042+117%3.594+1520%
Pe Ratio-25.398-17%-21.707-10.204-53%-1.944-91%-4.295-80%19.523-211%
Price Per Share9.700+15%8.2905.148+61%2.370+250%3.850+115%2.039+307%
Price To Free Cash Flow Ratio27.106+15%23.166-2.113+109%-3.218+114%-2.984+113%-12.348+153%
Price To Total Gains Ratio21.757+15%18.594-587.661+3260%-14.733+179%-125.157+773%3.416+444%
Quick Ratio--1.1050.685+61%0.538+105%0.569+94%0.668+65%
Return On Assets---0.064-0.175+175%-0.329+416%-0.712+1015%-0.526+724%
Return On Equity---1.065-0.266-75%-1.154+8%-1.705+60%-1.210+14%
Total Gains Per Share--0.4460.102+336%-0.192+143%0.020+2115%0.011+3986%
Usd Book Value--5566159.000-5771027.750+204%4736725.250+18%-693885.200+112%-252429.075+105%
Usd Book Value Change Per Share--0.4260.082+417%-0.212+150%0.006+6916%0.003+12301%
Usd Book Value Per Share--0.142-0.148+204%0.121+18%-0.018+112%-0.006+105%
Usd Dividend Per Share--0.0200.0200%0.0200%0.014+41%0.007+166%
Usd Eps---0.095-0.142+48%-0.311+226%-0.255+167%-0.131+38%
Usd Free Cash Flow--3496991.00021737.000+15988%-8957121.750+356%-4260412.700+222%-2213123.625+163%
Usd Free Cash Flow Per Share--0.0890.001+15988%-0.229+356%-0.109+222%-0.057+163%
Usd Free Cash Flow To Equity Per Share--0.4570.187+145%-0.233+151%0.044+949%0.021+2062%
Usd Market Cap379158450.000+15%324043665.000201208053.750+61%92639745.000+250%150471180.750+115%79681907.250+307%
Usd Price Per Share9.700+15%8.2905.148+61%2.370+250%3.850+115%2.039+307%
Usd Profit---3732102.000-6667613.000+79%-11642265.000+212%-9798485.450+163%-5056243.350+35%
Usd Revenue--44859847.00038136751.500+18%29758380.000+51%20685220.400+117%10849948.775+313%
Usd Total Gains Per Share--0.4460.102+336%-0.192+143%0.020+2115%0.011+3986%
 EOD+5 -3MRQTTM+29 -7YOY+30 -65Y+32 -410Y+32 -4

4.2. Fundamental Score

Let's check the fundamental score of LifeMD Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-25.398
Price to Book Ratio (EOD)Between0-168.119
Net Profit Margin (MRQ)Greater than0-0.083
Operating Margin (MRQ)Greater than0-0.048
Quick Ratio (MRQ)Greater than11.105
Current Ratio (MRQ)Greater than11.225
Debt to Asset Ratio (MRQ)Less than10.905
Debt to Equity Ratio (MRQ)Less than115.095
Return on Equity (MRQ)Greater than0.15-1.065
Return on Assets (MRQ)Greater than0.05-0.064
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of LifeMD Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.047
Ma 20Greater thanMa 5010.103
Ma 50Greater thanMa 1008.867
Ma 100Greater thanMa 2007.908
OpenGreater thanClose10.100
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Stockholder Equity -6,830-500-7,330-3,659-10,989-1,683-12,67116,1773,505
Net Debt  1694,7824,951-1,5483,4031,4584,861-19,075-14,214
Net Working Capital  -20,06312,209-7,854-3,483-11,3373,701-7,63615,4587,823



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets58,481
Total Liabilities52,915
Total Stockholder Equity3,505
 As reported
Total Liabilities 52,915
Total Stockholder Equity+ 3,505
Total Assets = 58,481

Assets

Total Assets58,481
Total Current Assets42,604
Long-term Assets15,876
Total Current Assets
Cash And Cash Equivalents 33,147
Net Receivables 5,277
Inventory 2,760
Other Current Assets 1,420
Total Current Assets  (as reported)42,604
Total Current Assets  (calculated)42,604
+/- 0
Long-term Assets
Property Plant Equipment 1,071
Intangible Assets 14,805
Long-term Assets Other 0
Long-term Assets  (as reported)15,876
Long-term Assets  (calculated)15,876
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities34,782
Long-term Liabilities18,133
Total Stockholder Equity3,505
Total Current Liabilities
Short-term Debt 931
Short Long Term Debt 328
Accounts payable 11,085
Other Current Liabilities 13,937
Total Current Liabilities  (as reported)34,782
Total Current Liabilities  (calculated)26,281
+/- 8,501
Long-term Liabilities
Long term Debt 17,928
Capital Lease Obligations Min Short Term Debt-254
Long-term Liabilities Other 131
Long-term Liabilities  (as reported)18,133
Long-term Liabilities  (calculated)17,805
+/- 328
Total Stockholder Equity
Common Stock384
Retained Earnings -214,265
Accumulated Other Comprehensive Income -384
Other Stockholders Equity 217,770
Total Stockholder Equity (as reported)3,505
Total Stockholder Equity (calculated)3,505
+/- 0
Other
Capital Stock384
Cash and Short Term Investments 33,147
Common Stock Shares Outstanding 36,711
Current Deferred Revenue8,829
Liabilities and Stockholders Equity 58,481
Net Debt -14,214
Net Invested Capital 21,761
Net Working Capital 7,823
Property Plant and Equipment Gross 1,071
Short Long Term Debt Total 18,932



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
> Total Assets 
0
0
0
370
365
462
293
551
328
302
313
175
216
252
245
448
641
866
1,079
790
790
1,074
1,337
1,264
1,264
1,838
1,899
2,616
2,616
2,199
2,546
3,446
2,291
3,024
5,429
13,054
18,744
23,988
16,352
49,923
50,290
37,969
33,362
25,666
33,870
35,446
40,691
58,481
58,48140,69135,44633,87025,66633,36237,96950,29049,92316,35223,98818,74413,0545,4293,0242,2913,4462,5462,1992,6162,6161,8991,8381,2641,2641,3371,0747907901,079866641448245252216175313302328551293462365370000
   > Total Current Assets 
0
0
0
212
222
333
178
451
241
230
255
131
187
236
245
448
641
866
1,079
790
790
1,074
1,337
1,264
1,264
1,471
1,564
1,605
1,605
1,329
1,761
2,747
1,572
2,191
4,653
12,063
17,838
22,480
14,133
44,921
29,579
18,510
12,974
11,311
19,165
20,181
24,886
42,604
42,60424,88620,18119,16511,31112,97418,51029,57944,92114,13322,48017,83812,0634,6532,1911,5722,7471,7611,3291,6051,6051,5641,4711,2641,2641,3371,0747907901,079866641448245236187131255230241451178333222212000
       Cash And Cash Equivalents 
0
0
0
99
39
111
47
155
36
61
90
75
70
80
74
233
204
235
474
183
183
381
563
141
141
691
407
180
180
265
781
1,107
358
336
917
9,179
13,407
17,414
9,447
41,328
25,085
11,717
5,837
3,959
11,525
11,907
15,288
33,147
33,14715,28811,90711,5253,9595,83711,71725,08541,3289,44717,41413,4079,1799173363581,10778126518018040769114114156338118318347423520423374807075906136155471113999000
       Net Receivables 
0
0
0
50
114
158
11
209
117
85
111
15
73
135
132
154
299
451
475
447
447
556
277
399
399
64
176
99
99
103
65
97
282
436
414
648
1,351
1,612
1,497
980
1,797
2,514
2,538
2,835
2,937
3,669
4,419
5,277
5,2774,4193,6692,9372,8352,5382,5141,7979801,4971,6121,35164841443628297651039999176643993992775564474474754512991541321357315111851172091115811450000
       Other Current Assets 
0
0
0
0
0
0
0
132
0
0
0
0
0
0
0
0
0
0
0
0
2
74
120
0
17
125
251
0
270
126
116
443
316
329
370
155
105
447
689
793
843
873
815
687
1,074
672
1,304
1,420
1,4201,3046721,07468781587384379368944710515537032931644311612627002511251701207420000000000001320000000
   > Long-term Assets 
0
0
0
158
143
129
115
101
86
72
58
44
30
15
0
0
0
0
0
0
0
0
0
0
0
367
335
0
1,011
870
785
699
719
833
777
990
906
1,508
2,219
5,002
20,711
19,459
20,388
14,354
14,705
15,265
15,805
15,876
15,87615,80515,26514,70514,35420,38819,45920,7115,0022,2191,5089069907778337196997858701,011033536700000000000153044587286101115129143158000
       Property Plant Equipment 
0
0
0
158
143
129
115
101
86
72
58
44
30
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
27
25
24
22
20
18
274
250
243
268
1,986
2,140
2,018
1,823
1,682
1,577
1,373
1,224
1,071
1,0711,2241,3731,5771,6821,8232,0182,1401,9862682432502741820222425272800000000000000153044587286101115129143158000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,455
6,720
5,655
0
0
0
0
0
000005,6556,7209,4550000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
367
335
1,011
1,011
843
759
675
697
813
758
716
656
1,264
1,951
3,016
9,116
10,722
12,910
12,672
13,128
13,893
14,581
14,805
14,80514,58113,89313,12812,67212,91010,7229,1163,0161,9511,2646567167588136976757598431,0111,0113353670000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
235
244
282
252
356
245
288
344
315
352
417
382
267
437
522
622
1,152
1,152
2,397
777
641
641
511
700
1,796
1,796
3,628
3,114
4,575
6,000
7,904
13,394
13,875
15,807
28,139
31,014
24,104
33,935
31,155
30,279
32,971
41,231
45,651
51,775
52,915
52,91551,77545,65141,23132,97130,27931,15533,93524,10431,01428,13915,80713,87513,3947,9046,0004,5753,1143,6281,7961,7967005116416417772,3971,1521,152622522437267382417352315344288245356252282244235000
   > Total Current Liabilities 
0
0
0
187
201
243
217
326
219
266
326
302
343
413
382
267
437
522
622
1,152
1,152
2,397
777
641
641
511
700
1,192
1,192
2,348
2,984
3,975
4,639
7,164
9,436
13,490
15,444
18,547
19,877
22,826
25,613
25,869
24,935
31,374
27,019
31,518
32,522
34,782
34,78232,52231,51827,01931,37424,93525,86925,61322,82619,87718,54715,44413,4909,4367,1644,6393,9752,9842,3481,1921,1927005116416417772,3971,1521,152622522437267382413343302326266219326217243201187000
       Short-term Debt 
0
0
0
0
0
0
10
40
28
23
67
27
92
98
106
100
100
100
214
100
206
25
77
125
167
63
-684
247
247
270
723
815
600
1,071
1,754
779
674
438
63
671
598
704
702
3,553
2,644
1,494
1,152
931
9311,1521,4942,6443,553702704598671634386747791,7541,071600815723270247247-6846316712577252061002141001001001069892276723284010000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
815
600
1,071
1,754
779
674
438
63
63
63
0
0
2,797
1,822
736
426
328
3284267361,8222,797006363634386747791,7541,0716008150000000000000000000000000000000
       Accounts payable 
0
0
0
187
0
0
207
285
191
243
259
274
0
314
0
0
0
422
0
0
753
562
700
0
473
446
684
0
0
0
0
3,051
3,687
5,628
7,052
11,735
13,430
11,664
9,257
9,059
11,676
11,939
10,798
10,107
6,903
9,593
9,637
11,085
11,0859,6379,5936,90310,10710,79811,93911,6769,0599,25711,66413,43011,7357,0525,6283,6873,0510000684446473070056275300422000314027425924319128520700187000
       Other Current Liabilities 
0
0
0
0
201
243
10
40
191
243
259
274
251
314
275
167
337
422
408
0
192
1,810
700
0
473
0
684
0
869
2,026
2,027
3,051
3,736
5,789
7,269
11,794
13,430
5,062
9,121
11,596
11,550
11,233
11,082
12,167
11,576
14,762
15,493
13,937
13,93715,49314,76211,57612,16711,08211,23311,55011,5969,1215,06213,43011,7947,2695,7893,7363,0512,0272,0268690684047307001,810192040842233716727531425127425924319140102432010000
   > Long-term Liabilities 
0
0
0
48
43
39
35
30
26
22
18
13
9
5
0
0
128
66
157
0
0
0
0
0
0
0
0
0
604
1,280
130
600
1,361
740
3,958
385
363
9,593
11,137
1,279
8,323
5,286
5,343
1,597
14,212
14,134
19,253
18,133
18,13319,25314,13414,2121,5975,3435,2868,3231,27911,1379,5933633853,9587401,3616001301,280604000000000157661280059131822263035394348000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,252
10,820
0
0
0
0
0
13,423
13,539
0
0
0013,53913,4230000010,8209,2520000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,656
3,778
3,881
3,996
4,111
0
4,336
4,451
4,566
4,678
5,033
0
0
005,0334,6784,5664,4514,33604,1113,9963,8813,7783,65600000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
570
1,332
711
3,930
100
100
100
100
100
7,117
4,415
4,638
1,023
0
319
0
0
0031901,0234,6384,4157,1171001001001001003,9307111,3325700000000000000000000000000000000
> Total Stockholder Equity
0
0
0
135
121
180
41
195
83
15
-30
-139
-136
-166
-137
100
77
278
300
0
-355
-1,060
818
0
882
1,316
1,254
0
898
-1,515
-470
-988
-3,394
-4,410
-7,294
1,354
3,704
-3,150
-13,562
26,851
17,398
7,847
3,883
-6,830
-7,330
-10,989
-12,671
3,505
3,505-12,671-10,989-7,330-6,8303,8837,84717,39826,851-13,562-3,1503,7041,354-7,294-4,410-3,394-988-470-1,51589801,2541,3168820818-1,060-355030027877100-137-166-136-139-30158319541180121135000
   Common Stock
0
0
0
289
289
294
294
301
302
302
307
307
307
306
307
320
320
343
347
0
356
405
443
0
445
439
453
0
458
469
534
534
541
711
156
234
259
266
269
307
309
310
315
316
320
326
348
384
384348326320316315310309307269266259234156711541534534469458045343944504434053560347343320320307306307307307302302301294294289289000
   Retained Earnings Total Equity00-202,858-195,348-190,563-177,851-169,7930-141,921-122,938-108,585-91,754-80,15200000000000000000000000000000000000
   Accumulated Other Comprehensive Income -3840-5,0330000000000-3,54100000000000000000-679-679000-63600000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,779
91,586
101,451
105,275
164,518
0
173,157
177,132
179,015
183,184
186,674
0
0
00186,674183,184179,015177,132173,1570164,518105,275101,45191,58677,77900000000000000000000000000000000000
   Treasury Stock00-164-164-164-164-1640-164-164-164-164-16400000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
7,641
7,668
7,739
7,739
7,958
7,985
7,989
8,043
8,713
8,080
8,072
8,092
9,046
8,405
8,783
9,028
0
8,983
9,273
11,055
0
11,337
11,756
12,229
0
12,581
12,959
14,879
15,073
16,304
18,584
40,451
77,616
91,422
101,287
105,112
164,354
168,863
172,994
176,968
178,852
183,020
191,543
196,738
217,770
217,770196,738191,543183,020178,852176,968172,994168,863164,354105,112101,28791,42277,61640,45118,58416,30415,07314,87912,95912,581012,22911,75611,337011,0559,2738,98309,0288,7838,4059,0468,0928,0728,0808,7138,0437,9897,9857,9587,7397,7397,6687,641000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue152,547
Cost of Revenue-26,533
Gross Profit126,014126,014
 
Operating Income (+$)
Gross Profit126,014
Operating Expense-140,504
Operating Income-14,489-14,489
 
Operating Expense (+$)
Research Development6,061
Selling General Administrative51,694
Selling And Marketing Expenses76,451
Operating Expense140,504134,206
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,597
Other Finance Cost-221
Net Interest Income-2,817
 
Pretax Income (+$)
Operating Income-14,489
Net Interest Income-2,817
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,411-11,567
EBIT - interestExpense = -17,086
-20,168
-17,999
Interest Expense2,597
Earnings Before Interest and Taxes (EBIT)-14,489-14,814
Earnings Before Interest and Taxes (EBITDA)-7,889
 
After tax Income (+$)
Income Before Tax-17,411
Tax Provision-428
Net Income From Continuing Ops-26,192-17,839
Net Income-20,596
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses167,036
Total Other Income/Expenses Net-2,9222,817
 

Technical Analysis of Lifemd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lifemd. The general trend of Lifemd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lifemd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of LifeMD Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.01.

The bearish price targets are: 9.22 > 9.11 > 8.93.

Tweet this
LifeMD Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of LifeMD Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

LifeMD Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of LifeMD Inc. The current macd is 0.20456906.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lifemd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Lifemd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Lifemd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
LifeMD Inc Daily Moving Average Convergence/Divergence (MACD) ChartLifeMD Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of LifeMD Inc. The current adx is 26.70.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lifemd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
LifeMD Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of LifeMD Inc. The current sar is 9.2456.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
LifeMD Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of LifeMD Inc. The current rsi is 50.05. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
LifeMD Inc Daily Relative Strength Index (RSI) ChartLifeMD Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of LifeMD Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lifemd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
LifeMD Inc Daily Stochastic Oscillator ChartLifeMD Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of LifeMD Inc. The current cci is -64.19517071.

LifeMD Inc Daily Commodity Channel Index (CCI) ChartLifeMD Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of LifeMD Inc. The current cmo is -7.76567561.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
LifeMD Inc Daily Chande Momentum Oscillator (CMO) ChartLifeMD Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of LifeMD Inc. The current willr is -70.55034051.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lifemd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
LifeMD Inc Daily Williams %R ChartLifeMD Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of LifeMD Inc.

LifeMD Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of LifeMD Inc. The current atr is 0.64614062.

LifeMD Inc Daily Average True Range (ATR) ChartLifeMD Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of LifeMD Inc. The current obv is 22,132,431.

LifeMD Inc Daily On-Balance Volume (OBV) ChartLifeMD Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of LifeMD Inc. The current mfi is 54.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
LifeMD Inc Daily Money Flow Index (MFI) ChartLifeMD Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for LifeMD Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

LifeMD Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of LifeMD Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.047
Ma 20Greater thanMa 5010.103
Ma 50Greater thanMa 1008.867
Ma 100Greater thanMa 2007.908
OpenGreater thanClose10.100
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lifemd with someone you think should read this too:
  • Are you bullish or bearish on Lifemd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lifemd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about LifeMD Inc

I send you an email if I find something interesting about LifeMD Inc.


Comments

How you think about this?

Leave a comment

Stay informed about LifeMD Inc.

Receive notifications about LifeMD Inc in your mailbox!